Get 24/7 incident response assistance from our global team
- APAC: +65 3159 4398
- EU & NA: +31 20 890 55 59
- MEA: +971 4 540 6400
- LATAM: +56 2 275 473 79
Get 24/7 incident response assistance from our global team
Please review the following rules before submitting your application:
1. Our main objective is to foster a community of like-minded individuals dedicated to combatting cybercrime and who have never engaged in Blackhat activities.
2. All applications must include research or a research draft. You can find content criteria in the blog. Please provide a link to your research or research draft using the form below.
Ransomware spreads quickly across networks, exploiting vulnerabiliti...
Explore solutions
Effectively safeguard your business assets against unseen risks...
Explore solutions
Your guide to AI innovation, adoption, and acceleration in cybersecurity

In this report, we share our key investigative findings and observations, including UNC2891’s tactics, techniques, and procedures.
Your guide to AI innovation, adoption, and acceleration in cybersecurity
Learn more
To look into the illegal use of pharma brands, Group-IB’s Digital Risk Protection team analyzed online sales of seven of the most common drugs produced by various manufacturers.
On-Demand
47 min
· March 24, 2020

In no other industry does the distribution of counterfeit products harm customers as much as in the pharmaceutical industry. Pharma brands must take proactive steps to stay ahead of criminals who counterfeit their drugs. Protection against the online distribution of suspicious medicinal products can be crucial.